For: | Zhang L, Mmagu O, Liu L, Li D, Fan Y, Baranchuk A, Kowey PR. Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients? World J Cardiol 2014; 6(8): 764-770 [PMID: 25228955 DOI: 10.4330/wjc.v6.i8.764] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v6/i8/764.htm |
Number | Citing Articles |
1 |
Efstathios D. Pagourelias, Georgios M. Alexandridis, Vassilios P. Vassilikos. Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessment. Heart Failure Reviews 2021; 26(6): 1297 doi: 10.1007/s10741-020-10058-6
|
2 |
Masato Shimizu, Mitsuhiro Nishizaki. Biomarkers in Cardiovascular Disease. 2015; : 1 doi: 10.1007/978-94-007-7741-5_26-1
|
3 |
Axel Sarrias, Enrique Galve, Xavier Sabaté, Roger Villuendas. La importancia de la estratificación de riesgo de muerte súbita en la miocardiopatía hipertrófica. Respuesta. Revista Española de Cardiología 2015; 68(6): 545 doi: 10.1016/j.recesp.2015.02.007
|
4 |
Masato Shimizu, Mitsuhiro Nishizaki. Biomarkers in Cardiovascular Disease. 2016; : 1135 doi: 10.1007/978-94-007-7678-4_26
|
5 |
Minjie Lu, Hui Du, Zhan Gao, Lei Song, Huaibing Cheng, Yan Zhang, Gang Yin, Xiuyu Chen, Jian Ling, Yong Jiang, Hao Wang, Jinghui Li, Jinghan Huang, Zuoxiang He, Shihua Zhao. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. Circulation: Cardiovascular Interventions 2016; 9(3) doi: 10.1161/CIRCINTERVENTIONS.115.002675
|
6 |
Dunia Bárbara Benítez Ramos, Michel Cabrera Ortega, Jesús Castro Hevia, Margarita Dorantes Sánchez, Ailema Amelia Alemán Fernández, Osmin Castañeda Chirino, Marlenis Cruz Cardentey, Frank Martínez López, Roylan Falcón Rodríguez. Electrocardiographic Markers of Appropriate Implantable Cardioverter-Defibrillator Therapy in Young People with Congenital Heart Diseases. Pediatric Cardiology 2017; 38(8): 1663 doi: 10.1007/s00246-017-1711-9
|
7 |
Karine Guerrier, Peace C Madueme, John L Jefferies, Jeffrey B Anderson, David S Spar, Timothy K Knilans, Richard J Czosek. Unexpectedly low left ventricular voltage on ECG in hypertrophic cardiomyopathy. Heart 2016; 102(4): 292 doi: 10.1136/heartjnl-2015-308633
|
8 |
Andrés Ricardo Pérez-Riera, Raimundo Barbosa-Barros, Mohammad Shenasa. Electrocardiographic Markers of Sudden Cardiac Death (Including Left Ventricular Hypertrophy). Cardiac Electrophysiology Clinics 2017; 9(4): 605 doi: 10.1016/j.ccep.2017.07.011
|
9 |
Loren Joseph, Milena Cankovic, Samuel Caughron, Pranil Chandra, Rajyasree Emmadi, Jill Hagenkord, Stephanie Hallam, Kay E. Jewell, Roger D. Klein, Victoria M. Pratt, Paul G. Rothberg, Robyn L. Temple-Smolkin, Elaine Lyon. The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer. The Journal of Molecular Diagnostics 2016; 18(5): 605 doi: 10.1016/j.jmoldx.2016.05.007
|
10 |
Guoliang Wang, Ruirui Ji, Wenxin Zou, Daniel J. Penny, Yuxin Fan. Inherited Cardiomyopathies: Genetics and Clinical Genetic Testing. Cardiovascular Innovations and Applications 2017; 2(2) doi: 10.15212/CVIA.2017.0015
|
11 |
|
12 |
|
13 |
Axel Sarrias, Enrique Galve, Xavier Sabaté, Roger Villuendas. Importance of Sudden Cardiac Death Risk Stratification in Hypertrophic Cardiomyopathy. Response. Revista Española de Cardiología (English Edition) 2015; 68(6): 545 doi: 10.1016/j.rec.2015.02.007
|
14 |
Guoliang Wang, Vivan Niewiadonski, Jianping Li, Ruirui Ji, Wenxin Zou, Daniel J. Penny, Yuxin Fan. Next Generation Sequencing Based Clinical Molecular Diagnosis of Human Genetic Disorders. 2017; : 243 doi: 10.1007/978-3-319-56418-0_12
|
15 |
|